In addition, recent studies have identified that uremic toxins, especially indoxyl sulfate (IS), may exacerbate anemia in CKD by disrupting erythropoiesis through EPO-dependent mechanisms, primarily by inducing sub-G1 phase arrest. The gene discussed is EPO; the disease is chronic kidney disease.